This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Gilead Sciences, Inc.
Drug Names(s): GS-6620
Description: GS 6620 is a nucleotide polymerase (NS5B) inhibitor in development for the treatment of HCV.
GS 6620 News
Additional information available to subscribers only: